Michelle (Twitter: @michellemcbane) is passionate about working with amazing technology entrepreneurs applying disruptive technologies to solve problems in enterprise, health and consumer markets. Michelle is a skilled business professional with many years of combined operational and venture capital experience. Her background includes 16 years of venture capital investing early- and later-stage companies in ICT and Health, managerial and product development experience as well as sales and marketing roles in both engineering and scientific industries. Michelle co-founded StandUp Ventures in 2017, and leads investments in early-stage companies health and technology companies. Michelle is currently on the Board of Directors of several companies as a Board member or Observer and these include Sampler, tealbook, ODAIA, StoryTap, Emovi, MiMS & Acerta. She is also an investor in Figure1, Maple, Rank & Rubikloud who have raised substantial follow-on financings. Past exits include Cytochroma (acquired by OPKO) and Locationary (acquired by Apple). She is also a Board Member at the CVCA and co-chairs the CVCA D&I Committee. Michelle holds a Master of Business Administration (MBA) degree from McMaster University and Bachelor of Applied Science (B.A.Sc.) in Chemical Engineering from the University of Ottawa. For more info see www.standupvc.com

• 

  Advisor in Biomedical Zone

  Canada’s leading incubator for medical startups.

• 

  Directors in Canadian Venture Capital and Private Equity Association

  The CVCA is a non-governmental organisation which promotes the development of the Canadian venture capital and private equity industry.

• 

  Managing Director (Toronto) in StandUp Ventures

  We champion breakthrough companies led by women